SEC Form 4 · accession 0000905718-18-000450
Matinas BioPharma Holdings, Inc. · MTNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Wikler
Director
Period of report
Apr 30, 2018
Accepted (ET)
May 2, 2018 · 5:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001582554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.44 | Apr 30, 2018 | A | 100,000 | A | — | Apr 29, 2028 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F125% of the shares on April 30, 2019 and the remaining shares vest in equal monthly installments over the next 36 months.